Cormedix share price logo

Cormedix

NASDAQ: CRMD

Small Cap

$7.36

+0.04

(+0.55%)

Live

as on

Cormedix Stock Performance

as on October 10, 2026 at 5:09 am IST

  • Day's Low

    Day's High

    $7.26
    $7.46
    downward going graph

    1.36%

    Downside

    1.36%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.13
    $13.02
    downward going graph

    16.78%

    Downside

    76.90%

    Upside

    downward going graph

Cormedix share price movements today

Previous Close
$7.32
Open
$7.32
Volume
650.7K
Market Cap
$567.4M
Day's Low - High
$7.26 - $7.46
52 Week Low - High
$6.13 - $13.02

Cormedix Historical Returns

1 Month Return
-9.96 %
3 Month Return
-15.57 %
1 Year Return
-33.45 %
3 Year Return
+ 107.95 %
5 Year Return
+ 50.31 %

Cormedix Stock Fundamentals & Key Indicators

Check Cormedix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$567.4M

EPS (TTM)

2.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.07%

PE Ratio (TTM)

3.02

Industry PE ratio

-6.50

PEG Ratio

0.01

EBITDA

249.8M

Revenue (TTM)

462.2M

Profit Margin

82.78%

Return On Equity TTM

44.64%

Cormedix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cormedix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Cormedix image
Cormedix
Buy$567.4M50.31%3.0282.78%0.00%
Moderna image
Moderna
Neutral$78.4B-35.39%-24.62-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.2B181.24%29.1986.04%0.00%
Regeneron image
Regeneron
Buy$76.1B34.46%17.7284.86%0.50%

Stock Returns calculator for Cormedix Stock including INR - Dollar returns

The Cormedix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cormedix investment value today

Current value as on today

₹72,830

Returns

-₹27,170

(-27.17%)

Returns from Cormedix Stock

-₹33,091 (-33.09%)

Dollar Impact

₹5,921 (+5.92%)

Analyst Recommendation on Cormedix Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Cormedix. Average target price of $15.33

Cormedix Share Price Target

Get share price movements and forecasts by analysts on Cormedix.

What analysts predicted

51.99%UPSIDE

Target Price

$15.33

Current Price

$7.36

Analyzed by

2 Analysts

High

$15

Target

$15.33

Low

$14

Cormedix target price $15.33, a slight upside of 51.99% compared to current price of $7.36. According to 2 analysts rating.

Indian Investors' Interest in Cormedix Stock

Search interest for Cormedix Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-60% versus previous 30 day period

Cormedix Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
11
31
39
39
104
128
127
101
Gross Profit
0
0
10
30
37
37
93
107
105
77
Operating Income
-16
-15
-3
12
20
19
51
59
63
42
EBITDA
-15
-14
-2
13
20
20
57
68
66
57
Interest Expense
0
0
0
0
0
0
0
1
-
-
Depreciation
0
0
0
0
0
0
3
10
10
10
Income Before Tax
-15
-14
-2
13
20
20
52
56
55
38
Income Tax Expense
-1
-
-
-
-
0
-55
42
17
12
Net Income
-14
-14
-2
13
20
19
108
14
38
25
Net Profit Margin
0.00%
36.75%
94.01%
96.23%
95.91%
95.31%
89.26%
83.43%
82.50%
75.66%

Cormedix Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
-
43
311
Gross Profit
0
0
0
0
0
0
0
40
275
Operating Income
-32
-26
-21
-27
-29
-30
-48
-22
150
EBITDA
-32
-26
-20
-27
-29
-30
-46
-18
167
Interest Expense
0
0
0
0
0
0
0
0
2
Depreciation
0
0
0
0
0
0
0
0
14
Income Before Tax
-33
-26
-11
-27
-29
-30
-46
-19
150
Income Tax Expense
0
0
5
-5
-1
0
-
-1
-13
Net Income
-33
-26
-16
-22
-28
-29
-46
-17
163
Net Profit Margin
65.09%
7.68%
-31.76%
14.37%
22.00%
94.29%
0.00%
92.66%
88.46%

Cormedix Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-14
-2
13
20
19
108
14
38
-38
Operating Cash Flow
-17
-14
-13
-5
19
29
30
94
42
86
Investing Cash Flow
8
6
6
0
0
-20
-291
3
2
0
Financing Cash Flow
0
1
14
11
6
83
150
-1
-12
-7
Change in Cash
-8
-6
6
5
25
93
-109
96
33
78

Cormedix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-26
-16
-22
-28
-29
-46
-17
163
Operating Cash Flow
-28
-23
-15
-21
-21
-24
-38
-50
175
Investing Cash Flow
10
1
-12
7
-9
-3
-17
21
-308
Financing Cash Flow
20
29
25
40
41
17
55
26
238
Change in Cash
2
7
-1
25
11
-10
0
-3
105

Global Institutional Holdings in Cormedix

Check out the Institutions with significant holdings in Cormedix.

Funds
Holdings
Vanguard
4.87%
iShares
4.49%
VANGUARD INDEX FUNDS
3.92%
Avantis
3.23%
Chuck Royce
2.79%
See all

Cormedix News & Key Events

    Insights on Cormedix

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, CRMD stock has moved up by 108.0%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, CRMD has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 615.6% return, outperforming this stock by 649.1%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 38.60M → 25.98M (in $), with an average decrease of 32.7% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 3 quarters, 128.61M → 101.93M (in $), with an average decrease of 10.5% per quarter

    About Cormedix

    CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
    OrganisationCormedix
    Headquarters389 Interpace Pkwy, Parsippany, NJ, 07054, US
    IndustryBiotechnology
    CEOJoseph Todisco

    Key Management of Cormedix

    Name

    Title

    Mr. Joseph Todisco MBA

    CEO & Chairman of the Board of Directors

    Ms. Kaufman Beth Zelnick Esq.

    EVP, Chief Legal and Compliance Officer & Corporate Secretary

    Dr. Peter Sullivan BCOP, Pharm.D.

    Senior Vice President of Market Access

    Ms. Elizabeth Masson-Hurlburt B.A.

    Executive VP and Chief Operating & Commercial Officer

    Ms. Susan Blum

    EVP & Chief Financial Officer

    Ms. Beth Steinbrenner

    SVP & Chief Human Resource Officer

    Dr. Matthew T. David M.D.

    EVP & Chief Business Officer

    Donna Ucci

    Senior VP & Head of Global Quality

    Dr. Tushar Mukherjee

    Senior VP & Head of Technical Operations

    Mr. Jared L. Crandon Pharm.D.

    Executive Director of Clinical Portfolio Management

    FAQs

    What is Cormedix share price today?

    Cormedix share price today is $7.36 as on . Cormedix share today touched a day high of $7.46 and a low of $7.26.

    What is the 52 week high and 52 week low for Cormedix share?

    Cormedix share touched a 52 week high of $13.02 on and a 52 week low of $6.13 on . Cormedix stock price today i.e. is trending at $7.36,which is 43.47% down from its 52 week high and 20.16% up from its 52 week low.

    What is Cormedix's market capitalisation today?

    Cormedix market capitalisation is $0.00T as on .

    How to invest in Cormedix Stock (CRMD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Cormedix on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Cormedix Stock (CRMD) from India?

    Indian investors can start investing in Cormedix (CRMD) shares with as little as ₹96.730003356934 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹967.30 in Cormedix stock (as per the Rupee-Dollar exchange rate as on ). Based on Cormedix share’s latest price of $7.36 as on October 9, 2026 at 11:39 pm IST, you will get 1.3587 shares of Cormedix. Learn more about fractional shares .

    What are the returns that Cormedix has given to Indian investors in the last 5 years?

    Cormedix stock has given 50.31% share price returns and 27.85% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?